Measuring the effects of indomethacin on changes in cerebral oxidative metabolism and cerebral blood flow during sensorimotor activation
โ Scribed by K.S. St. Lawrence; F.Q. Ye; B.K. Lewis; J.A. Frank; A.C. McLaughlin
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 243 KB
- Volume
- 50
- Category
- Article
- ISSN
- 0740-3194
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
The work presented here uses combined blood oxygenation levelโdependent (BOLD) and arterial spin tagging (AST) approaches to study the effect of indomethacin on cerebral blood flow (CBF) and oxygen consumption (CMRO~2~) increases during motor activation. While indomethacin reduced the CBF increase during activation, it did not significantly affect the CMRO~2~ increase during activation. The ratio of the activationโinduced CBF increase in the presence and absence of indomethacin was 0.54 ยฑ 0.08 (ยฑSEM, n = 8, P < 0.001), while the ratio of the CMRO~2~ increase in the presence and absence of the drug was 1.02 ยฑ 0.08 (ยฑSEM, N = 8, ns). Potential difficulties in estimating CMRO~2~ changes from combined BOLD/AST data are discussed. Magn Reson Med 50:99โ106, 2003. Published 2003 WileyโLiss, Inc.
๐ SIMILAR VOLUMES
Regional cerebral blood flow (rCBF) was studied in nine patients with Alzheimer's disease before and after trestment with tacrine. A small but significant improvement in cognitive functioning on the drug was not accompanied by significant changes in rCBF for the group as a whole. However, when the a
## Abstract The lipid mediator prostaglandin E~2~ (PGE~2~) exhibits diverse biologic activity in a variety of tissues. Four PGE~2~ receptor subtypes (EP1โ4) are involved in various physiologic and pathophysiologic conditions, but differ in tissue distribution, ligandโbinding affinity, and coupling